References
- Akcam FZ, Tigli A, Kaya O, et al (2012). Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C. J Interferon Cytokine Res, 32, 570-4. https://doi.org/10.1089/jir.2012.0048
- Cheong JY, Cho SW, Oh B, et al (2010). Association of interleukin-18 gene polymorphisms with hepatitis B virus clearance. Dig Dis Sci, 55, 1113-9. https://doi.org/10.1007/s10620-009-0819-z
- El-Serag HB, Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76. https://doi.org/10.1053/j.gastro.2007.04.061
- Giedraitis V, He B, Huang WX, et al (2001). Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol, 112, 146-52. https://doi.org/10.1016/S0165-5728(00)00407-0
- Gracie JA, Koyama N, Murdoch J, et al (2005). Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun, 6, 211-6. https://doi.org/10.1038/sj.gene.6364183
- Hirankarn N, Manonom C, Tangkijvanich P, et al (2007). Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection. Tissue Antigens, 70, 160-3. https://doi.org/10.1111/j.1399-0039.2007.00865.x
- Hoshino T, Wiltrout RH, Young HA (1999). IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol, 162, 5070-7.
- Jiang H, Cao H, Liu G, et al (2014). IL-18 promoter -137G/C polymorphism correlates with chronic hepatitis B and affects the expression of interleukins. Acta Virol, 58, 28-33. https://doi.org/10.4149/av_2014_01_28
- Karra VK, Gumma PK, Chowdhury SJ, et al (2015). IL-18 polymorphisms in hepatitis B virus related liver disease. Cytokine, 73, 277-82. https://doi.org/10.1016/j.cyto.2015.02.015
- Kim YS, Cheong JY, Cho SW, et al (2009). A functional SNP of the Interleukin-18 gene is associated with the presence of hepatocellular carcinoma in hepatitis B virus-infected patients. Dig Dis Sci, 54, 2722-8. https://doi.org/10.1007/s10620-009-0970-6
- Kruse S, Kuehr J, Moseler M, et al (2003). Polymorphisms in the IL 18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol, 111, 117-22. https://doi.org/10.1067/mai.2003.43
- Lavanchy D (2004). Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat, 11, 97-107. https://doi.org/10.1046/j.1365-2893.2003.00487.x
- Li N, Gao YF, Zhang TC, et al (2012a). Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol, 4, 105-9. https://doi.org/10.4254/wjh.v4.i3.105
- Li Y, Shi Y, Chen J, et al (2012b). Association of polymorphisms in interleukin-18 and interleukin-28B with hepatitis B recurrence after liver transplantation in Chinese Han population. Int J Immunogenet, 39, 346-52. https://doi.org/10.1111/j.1744-313X.2012.01097.x
- Lin YJ, Wan L, Lee CC, et al (2007). Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patients. Genes Immun, 8, 302-7. https://doi.org/10.1038/sj.gene.6364387
- McKillop IH, Moran DM, Jin X, et al (2006). Molecular pathogenesis of hepatocellular carcinoma. J Surg Res, 136, 125-35. https://doi.org/10.1016/j.jss.2006.04.013
- Migita K, Sawakami-Kobayashi K, Maeda Y, et al (2009). Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease. Transl Res, 153, 91-6. https://doi.org/10.1016/j.trsl.2008.11.008
- Mojtahedi Z, Naeimi S, Farjadian S, et al (2006). Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabet Med, 23, 235-9. https://doi.org/10.1111/j.1464-5491.2006.01786.x
- Moradpour D, Blum HE (2005). Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 17, 477-83. https://doi.org/10.1097/00042737-200505000-00002
- Motavaf M, Safari S, Alavian SM (2014). Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection: a review study. Hepat Mon, 14, 19879.
- Nakanishi K, Yoshimoto T, Tsutsui H, et al (2001). Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol, 19, 423-74. https://doi.org/10.1146/annurev.immunol.19.1.423
- Okamura H, Tsutsi H, Komatsu T, et al (1995). Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature, 378, 88-91. https://doi.org/10.1038/378088a0
- Okamura H, Tsutsui H, Kashiwamura S, et al (1998). Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol, 70, 281-312. https://doi.org/10.1016/S0065-2776(08)60389-2
- Perrillo RP (2002). How will we use the new antiviral agents for hepatitis B? Curr Gastroenterol Rep, 4, 63-71. https://doi.org/10.1007/s11894-002-0039-6
- Pirhonen J, Sareneva T, Kurimoto M, et al (1999). Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol, 162, 7322-9.
- Qasem AA, Farag SE, Hamed E, et al (2014). Urinary biomarkers of acute kidney injury in patients with liver cirrhosis. ISRN Nephrol, 2014, 376795.
- Stephens M, Smith NJ, Donnelly P (2001). A new statistical method for haplotype reconstruction from population data. Am J Hum Genet, 68, 978-89. https://doi.org/10.1086/319501
- Taheri M, Hashemi M, Eskandari-Nasab E, et al (2012). Association of -607 C/A polymorphism of IL-18 gene (rs1946518) with breast cancer risk in Zahedan, Southeast Iran. Prague Med Rep, 113, 217-22.
- Tsai HT, Hsin CH, Hsieh YH, et al (2013). Impact of interleukin-18 polymorphisms -607A/C and -137G/C on oral cancer occurrence and clinical progression. PLoS One, 8, 83572. https://doi.org/10.1371/journal.pone.0083572
- Tuncbilek S (2014). Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection. World J Gastroenterol, 20, 6226-35. https://doi.org/10.3748/wjg.v20.i20.6226
- Wang KX, Peng JL, Wang XF, et al (2003). Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B. World J Gastroenterol, 9, 2017-20. https://doi.org/10.3748/wjg.v9.i9.2017
- Wen W, Zhang L, Xiao H (2001). [The transcription and expression of IL-18 gene in HBV infectors]. Zhonghua Yi Xue Za Zhi, 81, 655-8.
- World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 (Revised October 2000). WHO Web site. 2000. http://who.int/inf-fs/en/fact204.html.
- Wu DL, Xu GH, Lu SM, et al (2013). Correlation of AIM2 expression in peripheral blood mononuclear cells from humans with acute and chronic hepatitis B. Hum Immunol, 74, 514-21. https://doi.org/10.1016/j.humimm.2013.01.022
- Wu L, Chen L, Zhou L, et al (2011). Association of interleukin 18 gene promoter polymorphisms with HBV recurrence after liver transplantation in Han Chinese population. Hepat Mon, 11, 469-74.
- Xia P, Zhou M, Dong DS, et al (2014). Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a metaanalysis. Tumour Biol, 35, 1129-37. https://doi.org/10.1007/s13277-013-1151-y
- Xin-min GJ-mZY-lDHTHXYY (2010). Relationship between HBV infection and polymorphism of IL-18 promoter gene among three minority populations in Yunnan province. Chin J Clinicians ( Electronic Edition), 4, 1525-31.
- Yin J, Xie J, Liu S, et al (2011). Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol, 106, 81-92. https://doi.org/10.1038/ajg.2010.399
- Yu MW, Chen CJ (1994). Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol, 17, 71-91. https://doi.org/10.1016/1040-8428(94)90020-5
- Zhang PA, Wu JM, Li Y, et al (2005). Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol, 11, 1594-8. https://doi.org/10.3748/wjg.v11.i11.1594
- Zhang Y, Li Y, Ma Y, et al (2011). Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cells metastasis. Am J Physiol Gastrointest Liver Physiol, 301, G565-73. https://doi.org/10.1152/ajpgi.00058.2011
- Zhou Y, Yamaguchi E, Hizawa N, et al (2005). Roles of functional polymorphisms in the interleukin-18 gene promoter in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, 22, 105-13.